New US Patent Granted to Sabinsa

September 30, 2006

Sabinsa has been granted US patent #7,063,861, for Garcitrin®, a branded ingredient that offers effective weight management support. The patent, entitled “Bio-available Composition of Natural and Synthetic HCA” describes the use of the natural bioactive hydroxycitric acid (HCA) in combination with garcinol in weight management.

HCA is a well-researched compound, clinically proven to support weight management. However, because HCA is poorly absorbed into target cells, it is ineffective alone as an inhibitor for adenosine triphosphate citratelyase, a key enzyme in body fat formation.

Sabinsa’s proprietary ingredient Garcitrin combines HCA with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits.

View Newsletter (PDF)